Fusion Pharmaceuticals Ownership 2024 | Who Owns Fusion Pharmaceuticals Now?
Institutional Ownership
94.52%
Insider Ownership
0.47%
Retail Ownership
5.01%
Institutional Holders
140.00
Fusion Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRED ALGER MANAGEMENT, LLC | - | - | - | -167,415 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -605,742 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -258,200 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -71,496 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -13,983 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -77,700 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -33,036 | -100.00% | - | Jun 30, 2024 |
| JOHNSON & JOHNSON | - | - | - | -3,670,516 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,683 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,836,739 | -100.00% | - | Jun 30, 2024 |
| FIL LTD | - | - | - | -4,187,271 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -56,925 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -38,101 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -9,669 | -100.00% | - | Jun 30, 2024 |
| GAMCO INVESTORS, INC. ET AL | - | - | - | -11,450 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -32,097 | -100.00% | - | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -501 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -47,260 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -298,034 | -100.00% | - | Jun 30, 2024 |
Fusion Pharmaceuticals's largest institutional shareholder is FRED ALGER MANAGEMENT, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRED ALGER MANAGEMENT, LLC | - | - | - | -167,415 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -605,742 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -258,200 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -71,496 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -13,983 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -77,700 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -33,036 | -100.00% | - | Jun 30, 2024 |
| JOHNSON & JOHNSON | - | - | - | -3,670,516 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,683 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,836,739 | -100.00% | - | Jun 30, 2024 |
| FIL LTD | - | - | - | -4,187,271 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -56,925 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -38,101 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -9,669 | -100.00% | - | Jun 30, 2024 |
| GAMCO INVESTORS, INC. ET AL | - | - | - | -11,450 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -32,097 | -100.00% | - | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -501 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -47,260 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -298,034 | -100.00% | - | Jun 30, 2024 |
The largest Fusion Pharmaceuticals shareholder by % of total assets is FRED ALGER MANAGEMENT, LLC. The company owns 0.00 shares of Fusion Pharmaceuticals (FUSN), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SCARBOROUGH ADVISORS, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -26 | -100.00% | - | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | - | - | - | -85 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -86 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -268 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -349 | -100.00% | - | Jun 30, 2024 |
| TOTH FINANCIAL ADVISORY CORP | - | - | - | -501 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -508 | -100.00% | - | Jun 30, 2024 |
| TD WATERHOUSE CANADA INC. | - | - | - | -700 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -924 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -1,600 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -2,949 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -5,252 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -7,800 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,683 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -9,669 | -100.00% | - | Jun 30, 2024 |
| GREENLAND CAPITAL MANAGEMENT LP | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| CRYSTALLINE MANAGEMENT INC. | - | - | - | -11,207 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Fusion Pharmaceuticals's largest institutional buyer is SCARBOROUGH ADVISORS, LLC. The company purchased -13.00 stocks of FUSN, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | - | - | - | -10,811,153 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -6,825,395 | -100.00% | - | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -6,500,328 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -6,401,000 | -100.00% | - | Jun 30, 2024 |
| FIL LTD | - | - | - | -4,187,271 | -100.00% | - | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -3,781,778 | -100.00% | - | Jun 30, 2024 |
| JOHNSON & JOHNSON | - | - | - | -3,670,516 | -100.00% | - | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -3,116,966 | -100.00% | - | Jun 30, 2024 |
| TPG GP A, LLC | - | - | - | -2,551,794 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,836,739 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,608,882 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -1,501,283 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -987,178 | -100.00% | - | Jun 30, 2024 |
| TIG ADVISORS, LLC | - | - | - | -914,400 | -100.00% | - | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | - | - | - | -779,202 | -100.00% | - | Jun 30, 2024 |
| FORT BAKER CAPITAL MANAGEMENT LP | - | - | - | -768,100 | -100.00% | - | Jun 30, 2024 |
| 1832 ASSET MANAGEMENT L.P. | - | - | - | -734,321 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -657,385 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -605,742 | -100.00% | - | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -585,102 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Fusion Pharmaceuticals's biggest institutional seller is FEDERATED HERMES, INC.. The company sold -10.81M shares of FUSN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | - | - | - | -10,811,153 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -6,825,395 | -100.00% | - | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -6,500,328 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -6,401,000 | -100.00% | - | Jun 30, 2024 |
| FIL LTD | - | - | - | -4,187,271 | -100.00% | - | Jun 30, 2024 |
| PENTWATER CAPITAL MANAGEMENT LP | - | - | - | -3,781,778 | -100.00% | - | Jun 30, 2024 |
| JOHNSON & JOHNSON | - | - | - | -3,670,516 | -100.00% | - | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -3,116,966 | -100.00% | - | Jun 30, 2024 |
| TPG GP A, LLC | - | - | - | -2,551,794 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -1,836,739 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,608,882 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -1,501,283 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -987,178 | -100.00% | - | Jun 30, 2024 |
| TIG ADVISORS, LLC | - | - | - | -914,400 | -100.00% | - | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | - | - | - | -779,202 | -100.00% | - | Jun 30, 2024 |
| FORT BAKER CAPITAL MANAGEMENT LP | - | - | - | -768,100 | -100.00% | - | Jun 30, 2024 |
| 1832 ASSET MANAGEMENT L.P. | - | - | - | -734,321 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -657,385 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -605,742 | -100.00% | - | Jun 30, 2024 |
| ALPINE ASSOCIATES MANAGEMENT INC. | - | - | - | -585,102 | -100.00% | - | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | - | - | - | -579,769 | -100.00% | - | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | - | - | - | -563,385 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -516,795 | -100.00% | - | Jun 30, 2024 |
| SAND GROVE CAPITAL MANAGEMENT LLP | - | - | - | -490,547 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -486,971 | -100.00% | - | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | - | - | - | -449,041 | -100.00% | - | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | - | - | - | -399,748 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -352,485 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -339,200 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -298,034 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -283,926 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -276,400 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -258,200 | -100.00% | - | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -251,158 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -243,035 | -100.00% | - | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | - | - | - | -233,000 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -177,200 | -100.00% | - | Jun 30, 2024 |
| CHICAGO CAPITAL MANAGEMENT, LLC | - | - | - | -170,200 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -167,415 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -165,000 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -164,521 | -100.00% | - | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | - | - | - | -157,172 | -100.00% | - | Jun 30, 2024 |
| MASO CAPITAL PARTNERS LTD | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| GABELLI FUNDS LLC | - | - | - | -146,150 | -100.00% | - | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | - | - | - | -138,836 | -100.00% | - | Jun 30, 2024 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | - | - | - | -115,750 | -100.00% | - | Jun 30, 2024 |
| HARVEST MANAGEMENT LLC | - | - | - | -110,000 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | - | - | - | -107,737 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -103,298 | -100.00% | - | Jun 30, 2024 |
| CLEARALPHA TECHNOLOGIES LP | - | - | - | -102,350 | -100.00% | - | Jun 30, 2024 |
| KRYGER CAPITAL LTD | - | - | - | -100,284 | -100.00% | - | Jun 30, 2024 |
| NATIXIS | - | - | - | -99,000 | -100.00% | - | Jun 30, 2024 |
| AQR ARBITRAGE LLC | - | - | - | -86,040 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -85,700 | -100.00% | - | Jun 30, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -83,400 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -79,609 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -77,700 | -100.00% | - | Jun 30, 2024 |
| YARBROUGH CAPITAL, LLC | - | - | - | -76,872 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -71,496 | -100.00% | - | Jun 30, 2024 |
| GLAZER CAPITAL, LLC | - | - | - | -67,074 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -56,925 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -55,884 | -100.00% | - | Jun 30, 2024 |
| MAVEN SECURITIES LTD | - | - | - | -53,000 | -100.00% | - | Jun 30, 2024 |
| WEXFORD CAPITAL LP | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -47,260 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -41,907 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -39,041 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -38,101 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -36,079 | -100.00% | - | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | - | - | - | -35,000 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -33,036 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -32,919 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -32,097 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -31,000 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -30,280 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -30,200 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -28,917 | -100.00% | - | Jun 30, 2024 |
| JBF CAPITAL, INC. | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| MINT TOWER CAPITAL MANAGEMENT B.V. | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| FIFTH LANE CAPITAL, LP | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -20,800 | -100.00% | - | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | - | - | - | -18,774 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -17,911 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -17,623 | -100.00% | - | Jun 30, 2024 |
| BERYL CAPITAL MANAGEMENT LLC | - | - | - | -16,191 | -100.00% | - | Jun 30, 2024 |
| TITLEIST ASSET MANAGEMENT, LLC | - | - | - | -16,050 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -13,983 | -100.00% | - | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | - | - | - | -13,920 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -11,939 | -100.00% | - | Jun 30, 2024 |
| GAMCO INVESTORS, INC. ET AL | - | - | - | -11,450 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -11,400 | -100.00% | - | Jun 30, 2024 |
| CRYSTALLINE MANAGEMENT INC. | - | - | - | -11,207 | -100.00% | - | Jun 30, 2024 |
| GREENLAND CAPITAL MANAGEMENT LP | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -9,669 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -8,683 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -7,800 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -5,252 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -2,949 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -1,600 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
Fusion Pharmaceuticals's largest sold out institutional shareholder by shares sold is FEDERATED HERMES, INC., sold -10.81M shares, valued at -, as of undefined.
Fusion Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Clough Global Equity Fund | 1.26% | 78,000 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.70% | 31,407 | -23,571 | -42.87% | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.40% | 156,700 | - | - | Jan 31, 2024 |
| Clough Funds Trust | 0.33% | 13,800 | - | - | Jan 31, 2023 |
| ALGER INSTITUTIONAL FUNDS | 0.25% | 64,415 | 64,415 | - | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.22% | 82,290 | 82,290 | - | Dec 31, 2023 |
| ALGER FUNDS | 0.17% | 165,175 | 165,175 | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.17% | 3,288,642 | 3,268,642 | 16343.21% | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.15% | 388,880 | - | - | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.13% | 20,419 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.08% | 646,714 | -899,300 | -58.17% | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.03% | 160,310 | 160,310 | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.03% | 2,361,800 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,248,102 | 1,219,100 | 4203.50% | Feb 29, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 89,100 | 89,100 | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.01% | 7,593 | -7,593 | -50.00% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.01% | 107,110 | 107,110 | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 19,200 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.01% | 3,256 | -3,255 | -49.99% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 151,153 | - | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.01% | 3,255 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 21,785 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 17,822 | - | - | Mar 31, 2024 |
| Tekla Healthcare Opportunities Fund | 0.00% | 7,160 | -7,159 | -50.00% | Mar 31, 2024 |
| Tekla World Healthcare Fund | 0.00% | 3,689 | -3,689 | -50.00% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 22,300 | - | - | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 35,500 | 35,500 | - | Feb 29, 2024 |
| VANGUARD WHITEHALL FUNDS | 0.00% | 148,132 | 6,703 | 4.74% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 22,700 | 20,315 | 851.78% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 162,733 | 15,910 | 10.84% | Jan 31, 2024 |
| Federated Hermes World Investment Series, Inc. | 0.00% | 95,000 | -55,000 | -36.67% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 150,567 | - | - | Feb 29, 2024 |
| Series Portfolios Trust | 0.00% | 4,903 | 4,903 | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 25,700 | - | - | Feb 29, 2024 |
| Dunham Funds | 0.00% | 26,692 | 26,692 | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 39,781 | 39,781 | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 88,130 | 24,459 | 38.41% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 23,270 | 23,270 | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 878 | - | - | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 21,775 | 21,775 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 41,073 | 1,727 | 4.39% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 46,129 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 4,261 | - | - | Mar 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 7,456 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 2,382 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 980 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 300 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 100,000 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 75,821 | - | - | Mar 28, 2024 |
| PROSHARES TRUST | 0.00% | 5,410 | -2,438 | -31.07% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 353,425 | -22,893 | -6.08% | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 17,583 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,917 | 640 | 50.12% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,000 | 6,000 | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 400 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 1,900 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 12,500 | 12,500 | - | Feb 29, 2024 |
Fusion Pharmaceuticals's largest mutual fund holder by % of total assets is "Clough Global Equity Fund", owning 78.00K shares, compromising 1.26% of its total assets.
Fusion Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 140 | 68.67% |
| 31 Dec, 23 | 83 | 112.82% |
| 30 Sep, 23 | 39 | -2.50% |
| 30 Jun, 23 | 40 | 11.11% |
| 31 Mar, 23 | 36 | 20.00% |
| 31 Dec, 22 | 30 | -3.23% |
| 30 Sep, 22 | 31 | - |
| 30 Jun, 22 | 31 | 10.71% |
| 31 Mar, 22 | 28 | -12.50% |
| 31 Dec, 21 | 32 | -17.95% |
| 30 Sep, 21 | 39 | 2.63% |
| 30 Jun, 21 | 38 | 5.56% |
| 31 Mar, 21 | 36 | 2.86% |
| 31 Dec, 20 | 35 | 25.00% |
| 30 Sep, 20 | 28 | -46.15% |
| 30 Jun, 20 | 52 | - |
As of 31 Mar 24, 140 institutions are holding Fusion Pharmaceuticals's shares, representing an increase of 68.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 69,088,929 | 13.64% |
| 31 Dec, 23 | 60,795,560 | 21.84% |
| 30 Sep, 23 | 49,899,434 | -0.71% |
| 30 Jun, 23 | 50,257,178 | 10.27% |
| 31 Mar, 23 | 45,577,701 | 60.64% |
| 31 Dec, 22 | 28,373,326 | 6.74% |
| 30 Sep, 22 | 26,582,738 | -4.58% |
| 30 Jun, 22 | 27,860,099 | -1.27% |
| 31 Mar, 22 | 28,219,658 | 1.62% |
| 31 Dec, 21 | 27,770,285 | -0.29% |
| 30 Sep, 21 | 27,852,055 | 1.34% |
| 30 Jun, 21 | 27,483,051 | -0.34% |
| 31 Mar, 21 | 27,576,983 | 1.42% |
| 31 Dec, 20 | 27,191,503 | 6.18% |
| 30 Sep, 20 | 25,608,260 | -9.67% |
| 30 Jun, 20 | 28,349,199 | - |
Fusion Pharmaceuticals (FUSN) has 69.09M shares outstanding as of 31 Mar 24, up 13.64% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 94.52% | 1.22% |
| 31 Dec, 23 | 88.05% | 1.55% |
| 30 Sep, 23 | 75.29% | 0.86% |
| 30 Jun, 23 | 93.46% | 1.30% |
| 31 Mar, 23 | 84.75% | 2.11% |
| 31 Dec, 22 | 63.38% | 1.71% |
| 30 Sep, 22 | 60.85% | 1.47% |
| 30 Jun, 22 | 64.26% | 1.50% |
| 31 Mar, 22 | 65.37% | 1.54% |
| 31 Dec, 21 | 65.19% | 1.56% |
| 30 Sep, 21 | 64.74% | 1.55% |
| 30 Jun, 21 | 64.66% | 1.48% |
| 31 Mar, 21 | 66.00% | 1.55% |
| 31 Dec, 20 | 65.17% | 1.73% |
| 30 Sep, 20 | 61.38% | 1.33% |
| 30 Jun, 20 | 67.95% | - |
As of 31 Mar 24, Fusion Pharmaceuticals is held by 94.52% institutional shareholders, representing a 1.22% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 95 | 66.67% |
| 31 Dec, 23 | 57 | 375.00% |
| 30 Sep, 23 | 12 | -25.00% |
| 30 Jun, 23 | 16 | -11.11% |
| 31 Mar, 23 | 18 | 125.00% |
| 31 Dec, 22 | 8 | -38.46% |
| 30 Sep, 22 | 13 | 116.67% |
| 30 Jun, 22 | 6 | 50.00% |
| 31 Mar, 22 | 4 | -55.56% |
| 31 Dec, 21 | 9 | -50.00% |
| 30 Sep, 21 | 18 | -5.26% |
| 30 Jun, 21 | 19 | 18.75% |
| 31 Mar, 21 | 16 | -11.11% |
| 31 Dec, 20 | 18 | 100.00% |
| 30 Sep, 20 | 9 | -82.69% |
| 30 Jun, 20 | 52 | - |
95 institutional shareholders have increased their position in FUSN stock as of 31 Mar 24 compared to 57 in the previous quarter (a 66.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 13 | 62.50% |
| 31 Dec, 23 | 8 | - |
| 30 Sep, 23 | 8 | 60.00% |
| 30 Jun, 23 | 5 | 25.00% |
| 31 Mar, 23 | 4 | 33.33% |
| 31 Dec, 22 | 3 | - |
| 30 Sep, 22 | 3 | -62.50% |
| 30 Jun, 22 | 8 | 100.00% |
| 31 Mar, 22 | 4 | -42.86% |
| 31 Dec, 21 | 7 | -22.22% |
| 30 Sep, 21 | 9 | 50.00% |
| 30 Jun, 21 | 6 | -14.29% |
| 31 Mar, 21 | 7 | - |
| 31 Dec, 20 | 7 | -12.50% |
| 30 Sep, 20 | 8 | - |
| 30 Jun, 20 | - | - |
13 institutional shareholders have reduced their position in FUSN stock as of 31 Mar 24 compared to 8 in the previous quarter (a 62.50% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 140 | 68.67% | 69,088,929 | 13.64% | 94.52% | 1.22% | 95 | 66.67% | 13 | 62.50% |
| 31 Dec, 23 | 83 | 112.82% | 60,795,560 | 21.84% | 88.05% | 1.55% | 57 | 375.00% | 8 | - |
| 30 Sep, 23 | 39 | -2.50% | 49,899,434 | -0.71% | 75.29% | 0.86% | 12 | -25.00% | 8 | 60.00% |
| 30 Jun, 23 | 40 | 11.11% | 50,257,178 | 10.27% | 93.46% | 1.30% | 16 | -11.11% | 5 | 25.00% |
| 31 Mar, 23 | 36 | 20.00% | 45,577,701 | 60.64% | 84.75% | 2.11% | 18 | 125.00% | 4 | 33.33% |
| 31 Dec, 22 | 30 | -3.23% | 28,373,326 | 6.74% | 63.38% | 1.71% | 8 | -38.46% | 3 | - |
| 30 Sep, 22 | 31 | - | 26,582,738 | -4.58% | 60.85% | 1.47% | 13 | 116.67% | 3 | -62.50% |
| 30 Jun, 22 | 31 | 10.71% | 27,860,099 | -1.27% | 64.26% | 1.50% | 6 | 50.00% | 8 | 100.00% |
| 31 Mar, 22 | 28 | -12.50% | 28,219,658 | 1.62% | 65.37% | 1.54% | 4 | -55.56% | 4 | -42.86% |
| 31 Dec, 21 | 32 | -17.95% | 27,770,285 | -0.29% | 65.19% | 1.56% | 9 | -50.00% | 7 | -22.22% |
| 30 Sep, 21 | 39 | 2.63% | 27,852,055 | 1.34% | 64.74% | 1.55% | 18 | -5.26% | 9 | 50.00% |
| 30 Jun, 21 | 38 | 5.56% | 27,483,051 | -0.34% | 64.66% | 1.48% | 19 | 18.75% | 6 | -14.29% |
| 31 Mar, 21 | 36 | 2.86% | 27,576,983 | 1.42% | 66.00% | 1.55% | 16 | -11.11% | 7 | - |
| 31 Dec, 20 | 35 | 25.00% | 27,191,503 | 6.18% | 65.17% | 1.73% | 18 | 100.00% | 7 | -12.50% |
| 30 Sep, 20 | 28 | -46.15% | 25,608,260 | -9.67% | 61.38% | 1.33% | 9 | -82.69% | 8 | - |
| 30 Jun, 20 | 52 | - | 28,349,199 | - | 67.95% | - | 52 | - | - | - |
Fusion Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Fusion Pharmaceuticals's stock was made by Bitetti Teresa Marie on Jun 04 2024, selling 34,000 shares at $4.16 per share (valued at $141.44K).
Fusion Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 69 | - |
| Q1 2024 | 12 | - | - |
| Q4 2023 | 3 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 7 | - | - |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 9 | 5 | 180.00% |
| Q1 2022 | 5 | 19 | 26.32% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 7 | - | - |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 7 | - | - |
| Q4 2020 | 1 | 10 | 10.00% |
| Q2 2020 | 48 | 28 | 171.43% |
| Q1 2020 | 7 | 1 | 700.00% |
0 total buy trades, and 69 total sell trades (buy/sell ratio of 0.00%) were made by Fusion Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | - | 5 | - |
| Q1 2022 | - | 19 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 4 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 10 | - |
| Q2 2020 | 13 | - | - |
| Q1 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Fusion Pharmaceuticals's stocks.
Fusion Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| OLMA | Olema Pharmaceuticals, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| IKNA | Ikena Oncology, Inc. |
| BCAB | BioAtla, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| RLMD | Relmada Therapeutics, Inc. |
| JANX | Janux Therapeutics, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| KROS | Keros Therapeutics, Inc. |
| HRMY | Harmony Biosciences Holdings, Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| BCYC | Bicycle Therapeutics plc |
| RAPT | RAPT Therapeutics, Inc. |
FUSN Ownership FAQ
Who Owns Fusion Pharmaceuticals?
Fusion Pharmaceuticals is owned by institutional shareholders (94.52%), insiders (0.47%), and public (5.01%). The largest institutional shareholder of Fusion Pharmaceuticals is FRED ALGER MANAGEMENT, LLC (0% of total shares) and the top mutual fund owner is Clough Global Equity Fund (1.26% of total shares).
Who are the major institutional shareholders of Fusion Pharmaceuticals?
Fusion Pharmaceuticals's major institutional shareholders are FRED ALGER MANAGEMENT, LLC, JPMORGAN CHASE & CO, COWEN AND COMPANY, LLC, BANK OF AMERICA CORP /DE/, and WELLS FARGO & COMPANY/MN. The top five shareholders own together 0% of the company's share outstanding.
How many Fusion Pharmaceuticals shareholders are there?
As of Mar 2024, there are 140 institutional shareholders of Fusion Pharmaceuticals.
What percentage of Fusion Pharmaceuticals is owned by FRED ALGER MANAGEMENT, LLC?
FRED ALGER MANAGEMENT, LLC owns 0 shares of Fusion Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Fusion Pharmaceuticals is owned by JPMORGAN CHASE & CO?
As of Jun 2024, JPMORGAN CHASE & CO holds 0 shares of Fusion Pharmaceuticals (FUSN), compromising 0% of the company, valued at $0.
What percentage of Fusion Pharmaceuticals is owned by COWEN AND COMPANY, LLC?
COWEN AND COMPANY, LLC is the third largest holder of Fusion Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).